Abstract:Stabilization of bone structure and function involves multiple cell-to-cell and molecular interactions, in which the regulatory functions of post-translational modifications such as ubiquitination and deubiquitination shouldn't be underestimated. As the largest family of deubiquitinating enzymes, the ubiquitin-specific proteases (USPs) participate in the development of bone homeostasis and bone-related diseases through multiple classical osteogenic and osteolytic signaling pathways, such as BMP/TGF-β pathway, NF-κB/p65 pathway, EGFR-MAPK pathway and Wnt/β-catenin pathway. Meanwhile, USPs may also broadly regulate regulate hormone expression level, cell proliferation and differentiation, and may further influence bone homeostasis from gene fusion and nuclear translocation of transcription factors. The number of patients with bone-related diseases is currently enormous, making exploration of their pathogenesis and targeted therapy a hot topic. Pathological increases in the levels of inflammatory mediators such as IL-1β and TNF-α lead to inflammatory bone diseases such as osteoarthritis, rheumatoid arthritis and periodontitis. While impaired body metabolism greatly increases the probability of osteoporosis. Abnormal physiological activity of bone-associated cells results in a variety of bone tumors. The regulatory role of USPs in bone-related disease has received particular attention from academics in recent studies. In this review, we focuse on the roles and mechanisms of USPs in bone homeostasis and bone-related diseases, with the expectation of informing targeted therapies in the clinic.

The Role of Deubiquitinating Enzymes in Primary Bone Cancer

The Role of Deubiquitinating Enzymes in Hematopoiesis and Hematological Malignancies

Ubiquitin-specific proteases: Vital regulatory molecules in bone and bone-related diseases

Deubiquitinases in cancer

Ubiquitination in osteosarcoma: unveiling the impact on cell biology and therapeutic strategies

The Roles of Deubiquitinating Enzymes in Cancer Therapy

Dysregulation of deubiquitination in breast cancer

Functional analysis of deubiquitylating enzymes in tumorigenesis and development

Deubiquitylating Enzymes in Cancer and Immunity

The role of deubiquitinases in breast cancer

Emerging Role of DUBs in Tumor Metastasis and Apoptosis: Therapeutic Implication

Deubiquitinases in Hematological Malignancies

The role of the deubiquitinating enzyme DUB3/USP17 in cancer: a narrative review

Ubiquitination and deubiquitination in cancer: from mechanisms to novel therapeutic approaches

Roles and Mechanisms of Deubiquitinases (dubs) in Breast Cancer Progression and Targeted Drug Discovery

Deubiquitinating Enzymes and Bone Remodeling

Ubiquitin carboxyl-terminal hydrolases: involvement in cancer progression and clinical implications

The role of deubiquitinating enzymes in cancer drug resistance

The Potential Role of Ubiquitin C-Terminal Hydrolases in Oncogenesis

The Deubiquitinase UCHL1 Negatively Controls Osteoclastogenesis by Regulating TAZ/NFATC1 Signalling

Ubiquitin-Specific Proteases: Players in Cancer Cellular Processes